Harrington Investments INC lifted its stake in Healthpeak Properties, Inc. (NYSE:PEAK – Get Rating) by 10.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 28,657 shares of the company’s stock after acquiring an additional 2,755 shares during the quarter. Harrington Investments INC’s holdings in Healthpeak Properties were worth $718,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in PEAK. Invesco Ltd. lifted its holdings in Healthpeak Properties by 96.4% during the 1st quarter. Invesco Ltd. now owns 11,512,029 shares of the company’s stock worth $395,209,000 after buying an additional 5,650,120 shares in the last quarter. PGGM Investments acquired a new stake in Healthpeak Properties during the 3rd quarter worth approximately $121,461,000. Centersquare Investment Management LLC lifted its holdings in Healthpeak Properties by 203.6% during the 3rd quarter. Centersquare Investment Management LLC now owns 4,894,699 shares of the company’s stock worth $112,186,000 after buying an additional 3,282,598 shares in the last quarter. State Street Corp lifted its holdings in Healthpeak Properties by 8.8% during the 1st quarter. State Street Corp now owns 38,709,498 shares of the company’s stock worth $1,328,897,000 after buying an additional 3,142,939 shares in the last quarter. Finally, Eaton Vance Management lifted its holdings in Healthpeak Properties by 226.9% during the 1st quarter. Eaton Vance Management now owns 3,616,528 shares of the company’s stock worth $124,156,000 after buying an additional 2,510,133 shares in the last quarter. 92.04% of the stock is currently owned by institutional investors and hedge funds.
Healthpeak Properties Stock Performance
Healthpeak Properties stock traded down $0.65 during midday trading on Friday, hitting $20.74. 12,679,321 shares of the company’s stock were exchanged, compared to its average volume of 4,948,936. Healthpeak Properties, Inc. has a 12-month low of $20.61 and a 12-month high of $35.72. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.72 and a current ratio of 0.72. The stock has a market cap of $11.34 billion, a price-to-earnings ratio of 22.54, a price-to-earnings-growth ratio of 3.15 and a beta of 0.88. The firm’s 50 day simple moving average is $25.52 and its 200 day simple moving average is $24.96.
Healthpeak Properties Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, February 23rd. Stockholders of record on Thursday, February 9th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.79%. The ex-dividend date was Wednesday, February 8th. Healthpeak Properties’s payout ratio is 130.44%.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on PEAK shares. Barclays reduced their target price on shares of Healthpeak Properties from $34.00 to $33.00 and set an “overweight” rating on the stock in a report on Friday, February 10th. Jefferies Financial Group upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the company from $23.00 to $29.00 in a report on Monday, January 2nd. Citigroup reduced their price objective on shares of Healthpeak Properties from $30.00 to $27.50 and set a “buy” rating on the stock in a report on Tuesday, February 28th. Morgan Stanley raised their price objective on shares of Healthpeak Properties from $23.00 to $25.00 and gave the company an “equal weight” rating in a report on Friday, March 10th. Finally, Evercore ISI upgraded shares of Healthpeak Properties from an “in-line” rating to an “outperform” rating and set a $28.00 price objective on the stock in a report on Monday, November 21st. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, Healthpeak Properties has a consensus rating of “Hold” and a consensus price target of $30.05.
In other news, Director Christine Garvey sold 1,000 shares of Healthpeak Properties stock in a transaction dated Tuesday, December 27th. The shares were sold at an average price of $25.11, for a total value of $25,110.00. Following the sale, the director now owns 23,827 shares of the company’s stock, valued at $598,295.97. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, COO Thomas Klaritch acquired 1,517 shares of Healthpeak Properties stock in a transaction that occurred on Tuesday, March 7th. The stock was purchased at an average price of $23.21 per share, for a total transaction of $35,209.57. Following the completion of the purchase, the chief operating officer now directly owns 344,000 shares of the company’s stock, valued at $7,984,240. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Christine Garvey sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, December 27th. The shares were sold at an average price of $25.11, for a total transaction of $25,110.00. Following the completion of the sale, the director now owns 23,827 shares of the company’s stock, valued at approximately $598,295.97. The disclosure for this sale can be found here. Insiders have bought a total of 21,817 shares of company stock valued at $506,099 over the last quarter. Corporate insiders own 0.28% of the company’s stock.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community (CCRC). The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry.
- Get a free copy of the StockNews.com research report on Healthpeak Properties (PEAK)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Want to see what other hedge funds are holding PEAK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:PEAK – Get Rating).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.